Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

TCT.14: DKCRUSH-IV shows simpler is better in side branch stenting

Fractional flow reserve-guided side branch lesion stenting holds promise of fewer stents placed and more years between retreatment of stenosis, according to findings presented Sept. 14 at the Transcatheter Cardiovascular Therapeutics (TCT) conference.

Thumbnail

TCT.14: Heparin may come back in vogue, but in low doses

Heparin is making a comeback in a big way, according to one statement made Sept. 14 at the Transcatheter Cardiovascular Therapeutics (TCT) conference. The speaker went on to say it will become the anticoagulant of choice over bivalirudin and others.

TCT.14: Bioresorbable scaffolds appear safe at one year

Fewer patients with coronary artery disease who were treated with a bioresorbable scaffold experienced new or worsening angina after treatment than similar patients implanted with metal stents in the ABSORB II trial. The one-year results were presented Sept. 14 at the Transcatheter Cardiovascular Therapeutics scientific session.

TCT.14: TAVR extends survival by two years in inoperable patients

WASHIINGTON, D.C.—Transcatheter aortic valve replacement (TAVR) added more than two years to the life of inoperable patients with severe aortic stenosis, according to five-year results of the PARTNER I trial presented Sept. 13 at the Transcatheter Cardiovascular Therapeutics scientific session. The device also showed good durability, researchers said.

The importance of keeping afib warfarin control stable

Steady time in therapeutic range is important for optimal care when treating atrial fibrillation patients using warfarin. However, research published online Sept. 2 in Circulation: Cardiovascular Quality and Outcomes insists that stability, seen through the international normalized ratio, not be overlooked.

Thumbnail

Risks higher for women undergoing STEMI PCI

When treating ST-segment elevation myocardial infarction (STEMI) with percutaneous coronary intervention (PCI), does the patient’s sex have a role in their outcomes? According to a study published online Aug. 12 in Catheterization and Cardiovascular Outcomes, the answer is yes.

Thumbnail

Growing up on statins: Checking up on kids 10 years out

Children with familial hypercholesterolemia who were given statins as treatment slowed the progression of their mean carotid intima media thickness after 10 years of treatment to nearly normal rates, according to research published Sept. 10 in JAMA.

Playtime reduces heart failure risk

Thanks to a Swedish study, we can add one more benefit to the list when talking about increasing down-time activity levels: reduced heart failure risks.

Displaying 7241 - 7248 of 10742

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.